Northland Securities Upgrades Medifast (MED) to Outperform
Tweet
Share
E-mailGet Alerts MED Hot Sheet
Price: $11.44 --0%
Rating Summary:
4 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
4 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Northland Securities upgraded Medifast (NYSE: MED) from Market Perform to Outperform with a price target of $29.00 (from $16.00).
For an analyst ratings summary and ratings history on Medifast click here. For more ratings news on Medifast click here.
Shares of Medifast closed at $20.63 yesterday.
For an analyst ratings summary and ratings history on Medifast click here. For more ratings news on Medifast click here.
Shares of Medifast closed at $20.63 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- Freedom Broker Upgrades PrimeEnergy Resource (PNRG) to Hold
- HSBC Upgrades YPF S.A. (YPF) to Buy
Create E-mail Alert Related Categories
UpgradesRelated Entities
Northland SecuritiesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
